Cedar Park Dialysis Center is a medicare approved dialysis facility center in Cedar Park, Texas and it has 12 dialysis stations. It is located in Williamson county at 1720 E Whitestone Blvd, Cedar Park, TX, 78613. You can reach out to the office of Cedar Park Dialysis Center at (512) 528-8478. This dialysis clinic is managed and/or owned by Davita. Cedar Park Dialysis Center has the following ownership type - Profit. It was first certified by medicare in April, 2008. The medicare id for this facility is 672591 and it accepts patients under medicare ESRD program.
| Name | Cedar Park Dialysis Center |
|---|---|
| Location | 1720 E Whitestone Blvd, Cedar Park, Texas |
| No. of Dialysis Stations | 12 |
| Medicare ID | 672591 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1720 E Whitestone Blvd, Cedar Park, Texas, 78613 | |
| (512) 528-8478 | |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
| NPI Number | 1376737577 |
| Organization Name | Cedar Park Dialysis Center |
| Doing Business As | North Austin Dialysis Llc |
| Address | 1720 E Whitestone Blvd Cedar Park, Texas, 78613 |
| Phone Number | (512) 528-8478 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 66% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 21% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 13% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 61% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 9% | 14% |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 56% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 25% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 19% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 66% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 20% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 12% |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 79% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 21% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 60% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 12% |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 37 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 68 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 569 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
| Adult patients getting regular peritoneal dialysis at the center | 14 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 108 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 90 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Cedar Park Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 81 |
| Hypercalcemia patient months | 681 |
| Patients with Serumphosphor | 86 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 55 |
| Patient months included in arterial venous fistula and catheter summaries | 461 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 77 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 83 |
| Hospitalization Rate in facility | 157.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 286 |
| Hospitalization Rate: Lower Confidence Limit | 90 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at Cedar Park Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 20.6 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 32.2 |
| Readmission Rate: Lower Confidence Limit | 11.8 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Cedar Park Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.2 (As Expected) |
| SIR: Upper Confidence Limit | 2.65 |
| SIR: Lower Confidence Limit | .44 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Cedar Park Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 74 |
| Transfusion Rate in facility | 24.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 75.2 |
| Transfusion Rate: Lower Confidence Limit | 9.2 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
The rate of mortality show you whether patients who were being treated regularly at Cedar Park Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 376 |
| Mortality Rate in facility | 22.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 29.1 |
| Mortality Rate: Lower Confidence Limit | 16.6 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago
Fresenius Medical Care Of Cedar Park Location: 1201 North Lakeline Blvd., Cedar Park, Texas, 78613 Phone: (512) 259-1329 |
Cedar Park Dialysis Center Location: 1720 E Whitestone Blvd, Cedar Park, Texas, 78613 Phone: (512) 528-8478 |
News Archive
Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.
VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
› Verified 8 days ago